Shanghai, August 2026 – The 5th IMCAS China Congress is set to open on August 27–29, 2026 at the W Shanghai – The Bund. As one of the most anticipated gatherings in medical aesthetics, the event will bring together global experts, innovators, and clinicians. Among the featured exhibitors, Hangzhou Singclean Medical Products Co., Ltd. will make a strong impression by unveiling its premium hyaluronic acid filler Singderm® to the international community.

A Powerhouse Lineup of Expert Speakers

On the morning of August 27, Singclean will host a dedicated academic session in Meeting Room 2, 1st Floor:

• 10:00 AM – Dr. Zhu Yuan, a Singderm‑certified injection physician and Chief Expert in Bone‑Based Aesthetics at Huamei Group, will present “Precision Injection Strategy for Comprehensive Aesthetic Design,” sharing practical insights on harmonising facial architecture with soft‑tissue augmentation.

• 10:25 AM – Mr. Antoine Clavier‑Choo, Asia‑Pacific Chief Commercial Officer of HTL Biotechnology, will discuss the role of high‑grade biopolymers in regenerative medicine and the strategic partnership with Singclean.

• 10:40 AM – Dr. Diogo Melo, an internationally renowned oral and maxillofacial aesthetics educator and founder of the Diogo Melo Training Institute, will deliver “Full‑Face HA: Individualized Treatment Planning Based on Facial Patterns,” demonstrating how patient‑specific morphology guides optimal injection techniques.

Singderm®: Innovation Meets Clinical Excellence

Visitors to Booth #46 will discover why Singderm has gained global traction. Key product features include:

• High HA concentration – 24 mg/mL, with 90% cross‑linked via the patented SingLink® technology, ensuring strong lifting capacity and shape retention.

• Proven longevity – Clinical trial data show a 92.7% effectiveness rate at 12 months, outperforming leading competitors.

• Enhanced comfort – Formulated with 0.3% lidocaine and delivered in BD Hylok™ prefilled syringes for smooth, safe injection.

• Broad indications – Suitable for temples, cheeks, jawline, nose, lips, nasolabial folds, marionette lines, and chin, enabling full‑face rejuvenation.

• Global approvals – Certified by NMPA, CE, MHRA, TFDA, and Anvisa, with use in over 30 countries and annual sales exceeding 2 million syringes.

World‑Class Manufacturing Behind the Brand

Singclean operates Asia’s largest automated HA production facility (28,000 m²), with Class 10,000/100 cleanrooms, German aseptic filling, and Swedish terminal sterilisation, guaranteeing batch‑to‑batch consistency and safety.

A Glimpse into the Future

Beyond HA, Singclean is expanding its portfolio to include biostimulators (PLLA, CaHA), PDRN skin boosters, and post‑treatment care, aiming to offer comprehensive aesthetic solutions.

Join Singclean at IMCAS China 2026
The congress runs from August 27 to 29. Don’t miss the opportunity to experience Singderm firsthand at Booth #46 and attend the expert sessions on August 27. Singclean looks forward to welcoming clinicians and partners from around the world to explore the future of precision aesthetics.